Cargando…

Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world, and its 5-year survival rate is less than 20%, despite various treatments being available. Increasing evidence indicates that alternative splicing (AS) plays a nonnegligible role in the formation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shanshan, Cai, Luya, Liu, Chuan, Gu, Ruihong, Cai, Lingyi, Zhuo, Leying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034091/ https://www.ncbi.nlm.nih.gov/pubmed/33832428 http://dx.doi.org/10.1186/s10020-021-00294-3

Ejemplares similares

Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
por: Liu, Xuan, et al.
Publicado: (2021)

Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer
por: Yu, Shanshan, et al.
Publicado: (2020)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
por: Chen, Bo, et al.
Publicado: (2021)

Alternative splicing events are prognostic in hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Identification of prognostic alternative splicing events in sarcoma
por: Li, Hongshuai, et al.
Publicado: (2021)

Comprehensive characterization of 11 prognostic alternative splicing events in ovarian cancer interacted with the immune microenvironment
por: Yue, Congbo, et al.
Publicado: (2022)

Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma
por: Ye, Zai-Sheng, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
por: Gu, Xiangqian, et al.
Publicado: (2022)

Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer
por: Wu, Jian, et al.
Publicado: (2021)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer
por: Deng, Youyuan, et al.
Publicado: (2021)

A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma
por: Jin, Jingjing, et al.
Publicado: (2021)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Identification of Prognostic Stromal-Immune Score–Based Genes in Hepatocellular Carcinoma Microenvironment
por: Liu, Shanshan, et al.
Publicado: (2021)

Identification of Novel Alternative Splicing Events Associated With Tumorigenesis, Protein Modification, and Immune Microenvironment in Early-Onset Gastric Cancer
por: Zhang, Jian, et al.
Publicado: (2021)

Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis
por: Luo, Dingan, et al.
Publicado: (2021)

Comprehensive characterization of the alternative splicing landscape in ovarian cancer reveals novel events associated with tumor-immune microenvironment
por: Sun, Dan, et al.
Publicado: (2022)

Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells
por: Hu, Chuan, et al.
Publicado: (2020)

Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2021)

The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

The pattern of alternative splicing in lung adenocarcinoma shows novel events correlated with tumorigenesis and immune microenvironment
por: Wang, Gongjun, et al.
Publicado: (2021)

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
por: Zhu, Liping, et al.
Publicado: (2021)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Profiling of prognostic alternative splicing in melanoma
por: Ma, Fu-Chao, et al.
Publicado: (2019)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
por: Xiong, Yongfu, et al.
Publicado: (2020)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Characterization of alternative splicing events and prognostic signatures in breast cancer
por: Han, Pihua, et al.
Publicado: (2021)

Alternative Splicing Events in Immune Infiltration of Lung Adenocarcinoma
por: Huang, Tianpeng, et al.
Publicado: (2021)

Genome-wide identification, transcriptome analysis and alternative splicing events of Hsf family genes in maize
por: Zhang, Huaning, et al.
Publicado: (2020)

Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment
por: Li, Zhi-Xuan, et al.
Publicado: (2019)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Comprehensive Characterization of Alternative mRNA Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling
por: Zhao, Liang, et al.
Publicado: (2021)

Alternative Splicing in Hepatocellular Carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2020)

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rmp128sfe09fb1jeqmsuqvmsaj